The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Naproxen Sodium and Diphenhydramine HCl
Naproxen Sodium and Diphenhydramine HCl · NAPROXEN SODIUM 220 mg/1; DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1 · Tablet, Film Coated · Oral · Granules India Ltd
NDC 62207-0814-38 · 37500 TABLET, FILM COATED in 1 POUCH · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA213663
- TE code
- —
- Approval date
- Sep 24, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Naproxen Sodium and Diphenhydramine HCl (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Granules India Ltd | NAPROXEN SODIUM 220 mg/1; DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Granules India Ltd | NAPROXEN SODIUM 25 mg/1; DIPHENHYDRAMINE HYDROCHLORIDE 220 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Granules India Ltd | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Naproxen Sodium and Diphenhydramine HCl — NDC 62207-0814-38," retrieved September 3, 2026, https://drugdashboards.com/drug/62207081438.
Free to cite with attribution — see how the data is put together.